All, this may be a dumb point, and please correct me, but my understanding is that dogs with lymphoma B typically don't have long to live, so wouldn't recruiting them months early in readiness for trial administration agreements and ethics sign-offs etc be too late - tragically they just would not be alive or have a good prospect of living long enough (say 6 weeks) to complete a trial.
If that is the case, then I believe the status of play is understandable because early stage diagnosed dogs need to be available for this trial. If not we risk testing this new drug properly and boxing at shadows and diluting outcomes based on inconclusive results.
I think many of us had not appreciated that a couple of months ago, I had not. The learning is that PAA could have communicated that roadmap, plan and its design controls a little better so more people were less shocked and unnerved by an apparent delay with no explanation.
Regardless, I think management are doing a good job and I am excited at the prospect of trials starting in the near term.
GLTAH QQ
- Forums
- ASX - By Stock
- PAA
- Ann: Progress in Recruitment for Phase II Trial in Dogs
Ann: Progress in Recruitment for Phase II Trial in Dogs, page-28
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $82.65M |
Open | High | Low | Value | Volume |
17.0¢ | 18.0¢ | 17.0¢ | $23.82K | 136.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 125011 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 236237 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 125011 | 0.170 |
12 | 223341 | 0.165 |
8 | 332077 | 0.160 |
4 | 512800 | 0.155 |
10 | 378999 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 236237 | 5 |
0.185 | 264496 | 4 |
0.190 | 268528 | 5 |
0.195 | 182632 | 4 |
0.200 | 1144778 | 15 |
Last trade - 11.11am 15/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online